Petros Pharmaceuticals Inc (PTPI) Live Share Price, Invest From India

Petros Pharmaceuticals Inc Stock Performance

as on April 3, 2026 at 2:31 am IST

Day's Low
Day's High
$0.03
Day's Price Range
$0.03
$0.01
-200.00%
Downside
200.00%
Upside
52 Week's Low
52 Week's High
$0.06
52-Week Price Range
$2.62
$0.01
-501.00%
Downside
26050.00%
Upside

Petros Pharmaceuticals Inc share price movements today

Previous Close: $0.05
Open: $0.03
Volume: 100.0
Day's Low - High: $0.03 - $0.03
52 Week Low - High: $0.06 - $2.62

Petros Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Petros Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Petros Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Petros Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Petros Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Petros Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Petros Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Petros Pharmaceuticals Inc. Average target price of $1

Petros Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Petros Pharmaceuticals Inc.

What analysts predicted

99%UPSIDE

Target Price

Current Price

$0.01

Analyzed by

7 Analysts

Target

$1.00

Petros Pharmaceuticals Inc target price $1, a slight upside of 99% compared to current price of $0.01. According to 7 analysts rating.

Petros Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	2	1	1	0	1	1	1	0	-
Gross Profit	0	1	1	1	0	1	1	1	0	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-219	-2	-4	0	-8	0	-2	-9	-2
Net Profit Margin	-528.93%	-8713.45%	-127.72%	-271.67%	-87.34%	-577.97%	-46.57%	-140.87%	-1278.38%	0.00%

Petros Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	14	15	9	7	5	5	5
Gross Profit	3	8	5	6	3	4	3
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-32	-32	-20	-9	-27	-8	-14
Net Profit Margin	-231.10%	-208.71%	-215.35%	-119.77%	-451.22%	-140.20%	-280.10%

Global Institutional Holdings in Petros Pharmaceuticals Inc

Funds	Holdings
Geode Capital Management, LLC	0.07%
Vanguard Group Inc	0.06%
UBS Group AG	0.02%
Advisor Group Holdings, Inc.	0%
Group One Trading, LP	0%

See all

About Petros Pharmaceuticals Inc

Petros Pharmaceuticals, Inc. is focused on the self-care market by providing expanded access to key prescription pharmaceuticals such as OTC treatment options. The Company is engaged in developing a software-as-a-service (SaaS) platform designed to assist pharmaceutical companies in meeting FDA standards to assist in the Rx-to-OTC switch. In addition to the SaaS component, the platform is intended to incorporate software as a medical device (SaMD) capabilities, transforming traditional OTC medications into digitally enabled solutions. The SaMD interface seeks to be designed as customized and branded to pharmaceutical therapy and established as a specific application pathway to that therapy. Together, it aims to develop the SaaS and SaMD components to create a scalable, licensable platform that supports various classes of medications across the pharmaceutical industry, assisting pharmaceutical companies achieve regulatory approval, while delivering consumer-focused healthcare solutions.

Organisation	Petros Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Petros Pharmaceuticals Inc share price today?

Petros Pharmaceuticals Inc share price today is $0.01 as on April 2, 2026 at 9:01 pm IST at the close of the market. Petros Pharmaceuticals Inc share today touched a day high of $0.03 and a low of $0.03.

What is the 52 week high and 52 week low for Petros Pharmaceuticals Inc share?

Petros Pharmaceuticals Inc share touched a 52 week high of $2.62 on April 28, 2025 and a 52 week low of $0.06 on May 21, 2025. Petros Pharmaceuticals Inc stock price today i.e. April 2, 2026 at 9:01 pm IST is closed at $0.01,which is 99.62% down from its 52 week high and -83.36% up from its 52 week low.

How to invest in Petros Pharmaceuticals Inc Stock (PTPI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Petros Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Petros Pharmaceuticals Inc Shares that will get you 150.0000 shares as per Petros Pharmaceuticals Inc share price of $0.01 per share as on April 2, 2026 at 9:01 pm IST.

What is the minimum amount required to buy Petros Pharmaceuticals Inc Stock (PTPI) from India?

Indian investors can start investing in Petros Pharmaceuticals Inc (PTPI) shares with as little as ₹92.68 or $1 (as of April 4, 2026 at 6:32 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Petros Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 6:32 am IST). Based on Petros Pharmaceuticals Inc share’s latest price of $0.01 as on April 2, 2026 at 9:01 pm IST, you will get 1000.0000 shares of Petros Pharmaceuticals Inc. Learn more about fractional shares .